After ex-CEO’s indictment, what’s left of Vancouver biotech CytoDyn?


The Department of Justice unsealed a federal indictment on Tuesday charging Nader Pourhassan and an associate with defrauding investors.

Previous Watch for bioscience sector growth in 2023
Next Athena Health to pay $1.75M to settle claims over care of substance abuse patient